The Journal of Addiction Medicine Publishes Patient-centered Outcomes from the Phase 3 Study of SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection in Patients with Moderate to Severe Opioid Use Disorder (OUD) - P&T Community

Submitted by Anonymous (not verified) on Thu, 03/07/2019 - 15:30

The Journal of Addiction Medicine Publishes Patient-centered Outcomes from the Phase 3 Study of SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection in Patients with Moderate to Severe Opioid Use Disorder (OUD)  P&T CommunitySLOUGH, England and RICHMOND, Va., March 7, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the publication of patient-centered ...